BSAC News Alert Banco Santander-Chile Ads (BSAC) 20.16 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Banco Santander-Chile Ads (BSAC) 20.16 $BSAC

Banco Santander-Chile (BSAC) Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 12:41PM CST

BSAC: 20.16 (+0.16)

Banco Santander EPS of $0.48
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 4:17PM CST

BSAC: 20.16 (+0.16)

Banco Santander Chile Announces Fourth Quarter Earnings Report 2014
Thomson Reuters ONE - Wed Feb 04, 3:33PM CST
Santiago, Chile, February 4, 2015. Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its unaudited results for the fourth quarter of 2014[1].
BSAC: 20.16 (+0.16)

Is a Surprise Coming for Banco Santander-Chile (BSAC) This Earnings Season? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 8:00AM CST
Banco Santander-Chile is seeing favorable earnings estimate revision activity, suggesting a beat might be in the cards for the upcoming report.
BSAC: 20.16 (+0.16)

Banco Santander Chile Announces Fourth Quarter 2014 Analyst and Investor Webcast / Conference Call
Thomson Reuters ONE - Tue Jan 13, 11:56AM CST
Time: 9.00 am (Eastern Time)
BSAC: 20.16 (+0.16)

10 Ways To Benefit From The Power Of Dividends
David Hunkar - at Seeking Alpha - Fri Dec 26, 2:41PM CST
Dividend stocks can generate higher returns from an equity investment compared to non-dividend stocks. The total return from dividend stocks can get a significant boost from dividend reinvestment especially over the long term. The following chart...
BCH: 69.82 (+0.97), WBK: 29.31 (+0.64), BSAC: 20.16 (+0.16), EOC: 45.19 (+0.92), NGG: 68.59 (-0.46)

Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 28, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
CBZ: 8.60 (-0.06), DL: 18.44 (+0.60), CCM: 6.84 (-0.10), BSAC: 20.16 (+0.16)

Fitch Reviews Large Chilean Banks
Business Wire - Tue Nov 11, 12:44PM CST
Fitch Ratings has completed its review of Chile's four largest banks. As a result of the review, the Viability Ratings (VRs) and Issuer Default Ratings (IDRs) of Banco Santander Chile (BSC), Banco de Chile (BCH), Banco de Credito e Inversiones (BCI) and Banco del Estado de Chile (BEC) have been affirmed. The rating actions are summarized at the end of this press release.
BCH: 69.82 (+0.97), BSAC: 20.16 (+0.16)

Fitch Affirms Banco Santander Chile's IDR at 'A+'; Outlook Stable
Business Wire - Tue Nov 11, 10:38AM CST
Fitch Ratings has affirmed Banco Santander Chile's (BSC) Viability Ratings (VRs) and long-term Issuer Default Ratings (IDR) at 'a+' and 'A+' respectively. The Rating Outlook on the long-term IDRs is Stable. A complete list of rating actions is provided at the end of this release.
BSAC: 20.16 (+0.16)

Banco Santander misses by $0.20
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 8:25AM CST

BSAC: 20.16 (+0.16)

Banco Santander Chile Announces Third Quarter 2014 Earnings
Thomson Reuters ONE - Tue Nov 04, 6:21AM CST
Santiago, Chile, November 4, 2014. Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its unaudited results for the third quarter of 2014. These results are reported on a consolidated basis in accordance with Chilean Bank GAAP.
BSAC: 20.16 (+0.16)

Banco Santander Chile Announces Third Quarter 2014, Analyst And Investor Webcast / Conference Call
Thomson Reuters ONE - Mon Oct 20, 11:21AM CDT
Time: 11:00 am (Eastern Time)
BSAC: 20.16 (+0.16)

Santander Successfully Issues Its Second Mortgage Bond
Thomson Reuters ONE - Fri Sep 12, 10:42AM CDT
Santiago Chile, September 12, 2014. Banco Santander Chile placed in the local market its second Covered Mortgage Bond. The operation was executed via a Dutch auction system at the Santiago Stock Exchange for a total amount of UF 1,500,000 (US$61.3 million). This bond, due in 17.5 years, was placed at a rate of UF + 2.44%, representing a spread of 86 bps over BCU (Chilean Central Bank notes) with a similar maturity. This implies a 14 bps better spread than the Bank's senior debt spread. The placement agent was Santander Global Banking & Markets.
BSAC: 20.16 (+0.16)

Why the Earnings Streak Will Continue for Banco Santander-Chile (BSAC) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 27, 7:55AM CDT
Banco Santander-Chile, a firm in the financial sector, which could be a great candidate for another earnings beat
BSAC: 20.16 (+0.16)

Banco Santander-Chile (BSAC) is Oversold: Can It Recover? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 9:06AM CDT
Banco Santander-Chile (BSAC) is Oversold: Can It Recover?
BSAC: 20.16 (+0.16)

Banco Santander Chile Announces Second Quarter 2014 Earnings
Thomson Reuters ONE - Thu Jul 31, 5:31PM CDT
Santiago, Chile, July 31, 2014. Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its unaudited results for the second quarter of 2014. These results are reported on a consolidated basis in accordance with Chilean Bank GAAP.
BSAC: 20.16 (+0.16)

Banco Santander Chile Launches Free Investor Relations App
Thomson Reuters ONE - Thu Jul 31, 11:50AM CDT
Banco Santander Chile Launches Free Investor Relations App
BSAC: 20.16 (+0.16)

Will Barclays (BCS) Again Disappoint this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 29, 1:20PM CDT
Will Barclays (BCS) be able to reverse the trend this time or once again succumb to the tough industry backdrop?
BCS: 15.77 (+0.12), BBD: 12.90 (+0.30), BSAC: 20.16 (+0.16), HSBC: 46.13 (-0.01)

Will Deutsche Bank AG (DB) Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 4:00PM CDT
Deutsche Bank AG (DB) is scheduled to report its second-quarter 2014 results on Tuesday, Jul 29.
BBD: 12.90 (+0.30), RY: 62.26 (+0.23), BSAC: 20.16 (+0.16), DB: 32.29 (+0.70)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors of Sage Therapeutics Have Chance to Join Lawsuit

Updated Category News Views 88

Introduction to the Class Action Lawsuit Attention, investors! There's an important opportunity arising for shareholder litigation against Sage Therapeutics, Inc. The legal firm Bronstein, Gewirtz & Grossman, LLC is officially notifying individuals who have invested in Sage Therapeutics about a class action lawsuit that has now been filed. If you have faced substantial...

Continue Reading
FARO Technologies Revolutionizes 3D Metrology with Leap ST

Updated Category News Views 105

FARO Technologies Enhances 3D Metrology with Leap ST FARO Technologies, Inc. (NASDAQ: FARO) is pushing the boundaries of handheld scanning technology with the introduction of the Leap ST. This launch marks a significant expansion of FARO's product portfolio, positioning the company among the few firms offering a comprehensive range of portable 3D metrology solutions. Leap...

Continue Reading
Strong Financial Performance and Growth Strategies at TORM PLC

Updated Category News Views 181

TORM PLC Reports Robust Q3 2025 Financial Results TORM PLC has demonstrated remarkable resilience and adaptability, reporting its strongest quarterly results in 2025. This achievement underscores the effectiveness of TORM's integrated operating model, as highlighted by the CEO. The company continues to prioritize creating long-term value for its shareholders while...

Continue Reading
Manhattan Associates Faces Legal Challenges Amid Shareholder Losses

Updated Category News Views 304

Manhattan Associates Faces Legal Challenges Following Shareholder Loss In recent developments, Manhattan Associates, Inc. (NASDAQ: MANH) is under scrutiny as a class action lawsuit has been filed against the company. This action comes after an alarming drop in shareholder value, amounting to over $4 billion. The lawsuit is pivotal as it involves allegations of misleading...

Continue Reading
BioLife Solutions Announces Upcoming Financial Results

Updated Category News Views 91

BioLife Solutions to Share Key Financial Insights BioLife Solutions, Inc. (NASDAQ: BLFS), a pioneering developer and supplier of bioproduction products and services specializing in cell and gene therapies, is gearing up for a significant event. The company plans to release its financial results for the third quarter of 2024 after market hours on November 12, 2024. This is...

Continue Reading